Category: Joint ventures/collaborations
-
Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal
Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain.
-
Companies Partner on High-Resolution 3-D Tissue Printer
Two developers of tissue engineering technologies are building a three-dimensional bioprinter that produces high resolution, finely structured human tissue, including tiny blood vessels.
-
Self-Powered Sun Exposure Chip, App Developed
A tiny wireless sensor chip measuring exposure to ultraviolet or UV rays from the sun, developed by a university lab, is now offered by a cosmetics company with an accompanying smartphone app.
-
Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study
A collaboration of Mount Sinai medical center, drug maker Sanofi, and data science company Sema4 aims to track people with asthma for 5 years to help develop personalized treatments for the disease.
-
Project to Catalog Precision Lung Cancer Immunotherapies
A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer.
-
Prosthetic Joint Provides More Natural Wrist Movements
An academic-industry engineering team in Sweden developed and tested a prosthetic wrist joint that provides more natural movement and control than most current devices.
-
Company Formed to Advance Sickle Cell Gene Therapy
A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders.
-
Update – Verily Suspends Glucose-Sensing Contact Lens Project
An initiative developing a contact lens that measures blood glucose levels in tear fluid is now on hold, according to Verily Life Sciences, a division of Alphabet, the parent company of Google.
-
Trial Tests Diabetes Mgmt. Program vs. Smartphone Glucose Meter
A new clinical trial is testing a diabetes management program that includes Internet-connected glucose meters and one-on-one coaching against smartphone-enabled glucose meters alone.
-
DNA-Encoded Synthetic Antibodies Protect Against Ebola
Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses.